Announced Wed, 22 Apr · 20:46 IST
Mankind Pharma Limited has informed the Exchange about Credit Rating- New
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹2235.00
prior close
₹2238.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.3+0.3+2.8+1.4+1.6+1.3+0.7+0.4+4.2+12.1+10.0+13.4+14.6
Up moveDown movePending
AI summary
Mankind Pharma Limited has received new credit ratings from CARE Ratings Limited for its bank facilities worth ₹1,000 crore. The long-term rating is CARE AA+ with a Stable outlook, while the short-term rating is CARE A1+. These ratings have been assigned at the company's request and indicate a very strong credit profile. The rating represents the highest tier within the AA category, reflecting low credit risk.
Likely market impact
Positive for shareholders as the AA+ rating with Stable outlook signals strong financial health and low default risk, which could lead to better borrowing terms and enhanced investor confidence.